3 Downgraded Stocks to Sell in a Shaky Market

NYSE: MUX | McEwen Mining Inc.  News, Ratings, and Charts

MUX – McEwen Mining (MUX), Minerva Neurosciences (NERV), and American Resources Corporation (AREC) were recently downgraded in the POWR Ratings. Investors who own these stocks should reevaluate their positions as soon as possible. I.

Over the last two weeks, the market has been steadily moving lower. There are increasing signs of economic stress in terms of supply chain issues, coronavirus case counts continuing to rise, and signs that the consumer may be tapped out.


Investor uneasiness might weigh down the market in the months ahead, presenting some attractive buying opportunities, however in order to take advantage of these opportunities, investors should consider selling stocks with weak fundamentals and technicals.

McEwen Mining (MUX), Minerva Neurosciences (NERV), and American Resources Corporation (AREC) were recently downgraded in the POWR Ratings. Investors who own these stocks should reevaluate their positions as soon as possible.


MUX is a precious metal mining company that operates in the United States. MUX also evaluates potential mining sites outside of the continental United States yet its primary focus is on extracting valuable precious metals from right here at home.

MUX is a Strong Sell as it has an F POWR Rating grade. The stock has an F grade in the Quality and Momentum components of the POWR Ratings. MUX has D grades in the Value and Stability components. Investors who would like to find out how MUX performs in the rest of the POWR Ratings grades such as Sentiment and Growth can do so by clicking here.

Out of the 41 publicly traded companies in the Miners – Diversified space, MUX is ranked 33rd. You can find out more about this segment by clicking here.

MUX has a beta of 1.15, meaning it is not egregiously volatile. The stock is currently trading 28 cents above its 52-week low of 90 cents. MUX has a 52-week high of $1.71.

MUX’s price return last year was a disappointing -22.44%. The stock has a three-month price return of -19.73% and a three-year price return of -39.62%.


NERV, a clinical-stage biopharma corporation, is primarily focused on bringing treatments for central nervous system diseases to market. NERV’s drugs help treat those battling Parkinson’s disease, schizophrenia, insomnia, and depression.

NERV has an F POWR Rating grade along with D grades in the Quality, Momentum, Value, and Growth components. You can find out how NERV fares in the POWR Rating components of Sentiment and Stability by clicking here.

A total of 505 stocks comprise the Biotech category. NERV is ranked 480th out of these stocks. You can learn more about the Biotech category by clicking here.

NERV’s year-to-date price return is -28.63%. The stock had a 2020 price return of -67.09%. NERV’s three-year price return is even worse at -84.10%.

Investors fled NERV after its leading drug candidate, roluperidone, was declared to be a late-stage failure in late May. However, the stock temporarily bounced back soon after only to subsequently move back down below its prior May low.

NERV is now trading within 13 cents of its 52-week low of $1.54. The stock’s 52-week high is $4.12. NERV’s beta of 1.06 is comparably low so it probably won’t make a significant move even if the market soars. NERV is too risky to invest in at this point. Do not establish a position in NERV until the company releases some positive news about its treatments currently in the pipeline.


Located in Fishers, Indiana, AREC has operations in West Virginia and the Appalachian region to the east of Kentucky. AREC is primarily focused on extracting and processing pulverized and metallurgical coal. The company supplies such raw materials to infrastructure specialists.

AREC is a penny stock trading at $2.12. The stock’s 52-week low is $1.26. AREC’s 52-week high is a comparably lofty $8.02.

AREC’s POWR Rating components are as interesting as it gets. The stock has an F POWR Rating grade yet it has an A Momentum component grade and F grades in the Value and Stability components. You can find out how AREC grades out in the Value, Quality, and Growth components by clicking here.

AREC is ranked last out of 10 stocks in its Coal segment. Investors looking for Coal stocks to buy or short can learn more about the publicly traded companies that comprise this space by clicking here.

AREC’s latest quarterly revenue estimates did not come to fruition. The company reported a second-quarter loss. AREC’s latest quarterly loss of 13 cents per share is particularly disturbing as the consensus estimate was a loss of a mere six cents. AREC has failed to surpass consensus earnings per share estimates in each of the prior four quarters.

MUX shares were trading at $1.12 per share on Thursday afternoon, down $0.07 (-5.51%). Year-to-date, MUX has gained 13.71%, versus a 19.89% rise in the benchmark S&P 500 index during the same period.

About the Author: Patrick Ryan

Patrick Ryan has more than a dozen years of investing experience with a focus on information technology, consumer and entertainment sectors. In addition to working for StockNews, Patrick has also written for Wealth Authority and Fallon Wealth Management. More...

More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
MUXGet RatingGet RatingGet Rating
NERVGet RatingGet RatingGet Rating
ARECGet RatingGet RatingGet Rating

Most Popular Stories on StockNews.com

Inflation Not Fading Fast Enough for Stock Investors

Investors may have celebrated the end of high inflation too soon. The CPI report shows inflation bouncing higher and thus pushing back the start date for Fed rate cuts. This has the S&P 500 (SPY) coming off recent highs. This begs questions like how much more downside could we see? And when will the bull market get back on track? 44 year investment veteran Steve Reitmeister shares his answers to these questions in this timely commentary including a preview of his top picks to stay ahead of the pack. Read on below for more...

3 Auto Stocks to Consider Over TSLA in April

Tesla (TSLA) reported a decline in deliveries in the first quarter, and Wall Street expects the company to deliver fewer vehicles than last year. Furthermore, rising competition, slowing EV sales, and stretched valuation make TSLA unattractive from an investment standpoint. Considering these factors, investors could consider buying fundamentally strong auto stocks Blue Bird (BLBD), Rolls-Royce Holdings (RYCEY), and Stellantis (STLA) over Tesla (TSLA). Read more...

3 Top-Rated Tech Stock Buys for Value in April

The technology sector is undergoing a notable surge, propelled by increasing digitalization endeavors among businesses and governmental support for technological progress. So, fundamentally sound tech stocks Box Inc. (BOX), Teradata (TDC), and Materialise (MTLS), which seem pretty undervalued, might be ideal buys this month. Continue reading...

Top Software Stocks at the Forefront of Market Gains

The software industry's prospects appear bright due to increasing investments in digital transformation, high demand for advanced software services from various sectors, and the integration of emerging technologies such as generative AI. Therefore, investors could consider buying quality software stocks Autodesk (ADSK), DocuSign (DOCU), and Pegasystems (PEGA) for solid gains. Read more...

Updated 2024 Stock Market Outlook

The bull market continues to rage on with the S&P 500 (SPY) making new highs. That is the past...the question is what does the future hold? That is why 44 year investment veteran Steve Reitmeister provides this updated 2024 Stock Market Outlook to help you carve a path to outperformance the rest of the year. Read on below for the full story...

Read More Stories

More McEwen Mining Inc. (MUX) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All MUX News